CAS No. |
2166376-64-1 |
|---|---|
中文名称 |
(S)-N-(3-(4-((2S,6aS,6bR,7S,8aS,8bS,10R,11aR,12aS,12bS)-2,6b-二氟-7-羟基-8b-(2-羟基乙酰基)-6a,8a-二甲基-4-氧代-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-十二氢-1H-萘并[2',1':4,5]茚并[1,2-d][1,3]二氧杂环戊烯-10-基)苯氧基)苯基)-2-((S)-2-(3-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)丙酰胺基)丙酰胺基)丙酰胺 |
英文名称 |
(S)-N-(3-(4-((2S,6aS,6bR,7S,8aS,8bS,10R,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)phenoxy)phenyl)-2-((S)-2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)propanamido)propanamide |
别名 |
Glucocorticoid receptor agonist-2 Ala-Ala-Mal |
标准英文名 |
(S)-N-(3-(4-((2S,6aS,6bR,7S,8aS,8bS,10R,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-10-yl)phenoxy)phenyl)-2-((S)-2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanamido)propanamido)propanamide |
分子式 |
C47H50F2N4O12 |
分子量 |
900.93 |
精确分子量 |
900.34 |
SMILES |
C[C@H](NC(=O)CCN1C(=O)C=CC1=O)C(=O)N[C@@H](C)C(=O)NC1=CC(OC2=CC=C([C@@H]3O[C@@H]4C[C@H]5[C@@H]6C[C@H](F)C7=CC(=O)C=C[C@]7(C)[C@@]6(F)[C@@H](O)C[C@]5(C)[C@]4(C(=O)CO)O3)C=C2)=CC=C1 |
标准SMILES |
C[C@]12C=CC(=O)C=C1[C@@H](F)C[C@H]1[C@@H]3C[C@H]4O[C@H](O[C@@]4(C(=O)CO)[C@@]3(C)C[C@H](O)[C@]21F)C1C=CC(=CC=1)OC1C=C(C=CC=1)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CCN1C(=O)C=CC1=O |
用途 |
Glucocorticoid receptor agonist-2 Ala-Ala-Mal can be used for the synthesis of anti-inflammatory antibody-drug conjugates (ADCs); it serves as an active reference compound for ABBV-3373. |
InChIKey |
KRZIDULFZLGQNC-IVNSWYEUSA-N |
|
|
评论 |
|---|